It is Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.
My 2023 biotech outlook phone calls for ongoing momentum in identify alterations. I just have to ...
Read moreMy 2023 biotech outlook phone calls for ongoing momentum in identify alterations. I just have to ...
Read moreMy 2023 biotech outlook calls for ongoing momentum in title variations. I just will need to ...
Read moreAbbVie Inc. executives decreased their outlook for the quarter and yr in a filing with the ...
Read morePfizer is preparing to pull again on early-phase research into treatments for exceptional illnesses, which include ...
Read moreCytomX Therapeutics Inc. CTMX, +7.19% shares soared more than 50% in the extended session Thursday after ...
Read moreSeveral buyers have been functioning away from Tesla inventory in new weeks, apprehensive about disappointing auto ...
Read morePresident Joe Biden signed the Inflation Reduction Act (IRA) into law in August. Then he followed ...
Read moreA lot of investors have been functioning absent from Tesla stock in modern weeks, fearful about ...
Read moreShares of Kala Pharmaceuticals Inc. KALA, +36.35% have rocketed larger in for three-straight periods, toward a ...
Read moreShares of Generac Holdings Inc. surged Wednesday, just after Janney analyst Sean Milligan said the sharp ...
Read more